Epoqe Pharma
The vision is to prevent death and disability for millions of people worldwide suffering from cardiovascular diseases and to reduce the burden on individuals, families, and society.
The company uses a natural heart rescue mechanism, with strong preclinical validation scientific rationale, and a novel mode of action.
The primary indication is acute myocardial infarction, where the company has demonstrated convincing proof of concept data in several animal models.
